STOCK TITAN

AVIVAGEN to Present at The LD 500 Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Avivagen (TSXV:VIV, OTCQB:VIVXF), a life sciences company offering natural alternatives to antibiotics, will present at the LD 500 investor conference on September 3rd at 12:40 PM PST. Kym Anthony, CEO, will showcase the company to a live audience. This event, running from September 1st to 4th, marks a significant milestone as it becomes fully accessible due to COVID-19 restrictions. The founder of LD Micro emphasizes the importance of adapting to the times while highlighting unique companies in the market.

Positive
  • None.
Negative
  • None.

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:40 PM PST/9:40 AM EST. Kym Anthony, Chief Executive Officer will be presenting to a live audience.

Register here: https://ld-micro-conference.events.issuerdirect.com/

"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space." stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View AVIVAGEN'S profile here: http://www.Id/micro.com/profile/VIV

Profiles powered by LD Micro - News Compliments of Accesswire

About AVIVAGEN:

We are a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Drew Basek
Phone: 416-540-0733
Address:100 Sussex Drive
Ottawa, Ontario
Canada K1A 0R6
Email: d.basek@avivagen.com

SOURCE: Avivagen.com via LD Micro



View source version on accesswire.com:
https://www.accesswire.com/601582/AVIVAGEN-to-Present-at-The-LD-500-Virtual-Conference

FAQ

When is Avivagen presenting at the LD 500 conference?

Avivagen will present at the LD 500 investor conference on September 3rd at 12:40 PM PST.

What is Avivagen known for?

Avivagen is known for developing natural, patented alternatives to antibiotics for livestock and companion animals.

What are the dates for the LD 500 conference?

The LD 500 conference takes place from September 1st to 4th, 2020.

Who is presenting for Avivagen at the conference?

Kym Anthony, the Chief Executive Officer, will be presenting for Avivagen.

How can I register for the LD 500 conference?

You can register for the LD 500 conference at the provided link in the press release.

AVIVAGEN INC ORD

OTC:VIVXF

VIVXF Rankings

VIVXF Latest News

VIVXF Stock Data

7.77k
76.83M
1.11%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Ottawa